FDA Extends Biohaven's Troriluzole NDA PDUFA Date for Spinocerebellar Ataxia | MCQs Included

Stay updated on the latest FDA announcement regarding the extension of Biohaven's Troriluzole NDA PDUFA date for the rare disease Spinocerebellar Ataxia. This video provides essential information for Pharma students, covering key terms like FDA, Biohaven, Troriluzole, NDA, PDUFA, and Spinocerebellar Ataxia. Multiple-choice questions (MCQs) are included to test your understanding of this important development.
Video Credit to -Ivan_Samkov.mp4

Видео FDA Extends Biohaven's Troriluzole NDA PDUFA Date for Spinocerebellar Ataxia | MCQs Included канала MCQ Pedia